BIOMIND LABS INC. (3XI) — Working Capital to Net Assets Ratio
BIOMIND LABS INC. (3XI) has a Working Capital to Net Assets ratio of 100.0% as of September 2025. Working capital of €-1.56 Million (current assets of €57.72K minus current liabilities of €1.62 Million) is measured against net assets of €-1.56 Million. A higher ratio indicates strong short-term liquidity financed by the equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
BIOMIND LABS INC. Working Capital to Net Assets (2021–2024)
This chart shows how BIOMIND LABS INC.'s Working Capital to Net Assets ratio has evolved across 4 annual periods from 2021 to 2024. As of September 2025, the ratio stands at 100.0%, reflecting working capital of €-1.56 Million against net assets of €-1.56 Million EUR. For the complete balance sheet picture, see BIOMIND LABS INC. balance sheet assets.
Annual Working Capital to Net Assets for BIOMIND LABS INC. (2021–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for BIOMIND LABS INC. from 2021 to 2024, covering 4 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Read 3XI total liabilities for a breakdown of total debt and financial obligations.
| Year | WC/NA Ratio | Working Capital (EUR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 101.5% | €-1.32 Million | €-1.30 Million | €21.10K | €1.34 Million | ▼ -0.5 pp |
| 2023 | 102.0% | €-1.46 Million | €-1.43 Million | €45.22K | €1.51 Million | ▼ -15.8 pp |
| 2022 | 117.8% | €-291.79K | €-247.66K | €44.93K | €336.72K | ▲ +21.4 pp |
| 2021 | 96.4% | €2.11 Million | €2.19 Million | €2.44 Million | €324.69K | — |